These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
    Author: Ushigome E, Matsusaki S, Watanabe N, Hashimoto T, Nakamura N, Fukui M.
    Journal: J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596.
    Abstract:
    We aimed to investigate if estimated hemoglobin A1c (eHbA1c) levels determined using a flash continuous glucose monitoring system could be an indicator of glycemic control status in hemodialysis patients with diabetes. Hemodialysis patients with type 2 diabetes were recruited. eHbA1c levels were measured using the FreeStyle Libre Flash Glucose Monitoring System® . A total of 18 hemodialysis patients with diabetes were included in the study. The eHbA1cGA - calculated based on glycated albumin level, and body mass index and serum hemoglobin concentration were also included in the formula - was higher than the eHbA1c in most patients. Furthermore, the eHbA1cGA  - eHbA1c values were >2% in all patients with body mass index <18.5 kg/m2 ; the maximal value was 4.1%. This study shows that eHbA1c can be used as a reliable indicator for evaluating glycemic control and avoiding hypoglycemia in hemodialysis patients with diabetes, particularly those with decreased body mass index.
    [Abstract] [Full Text] [Related] [New Search]